CoVaRR-Net Funded Research Results

CoVaRR-Net Funded Research Results2022-08-09T12:55:08-04:00

Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals

March 26, 2024|Funded Research Results, Pillar 10|

Over the past 20 years, intense research efforts have focused on understanding and developing therapies for viruses with pandemic potential that have demonstrated the capacity to cross the species barrier, spread through respiratory routes, and lead to high hospitalization and mortality rates, such as coronaviruses and influenza viruses.

Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination

November 20, 2023|Study - SSO, Funded Research Results|

Novel COVID-19 vaccines have helped combat the COVID-19 pandemic by curbing transmission and decreasing the risk of severe disease. In randomised clinical trials (RCTs), COVID-19 vaccines were shown to produce high levels of antibodies against SARS-CoV-2.

Go to Top